Coherus BioSciences Inc. | Income Statement
Fiscal year is February-January. All values USD Millions.
2008
2009
2010
2011
2012
Sales/Revenue
3,010
2,475
2,065
2,062
1,992
Cost of Goods Sold (COGS) incl. D&A
2,199
1,847
1,117
1,115
1,050
Gross Income
811
628
947
947
942
SG&A Expense
777
692
583
599
578
Unusual Expense
113
115
48
24
11
Non Operating Income/Expense
9
4
1
1
6
Interest Expense
11
9
19
16
14
Pretax Income
81
183
92
57
5
Equity in Affiliates
-
-
-
-
-
Consolidated Net Income
84
169
78
54
2
Net Income
84
169
78
54
2
Net Income After Extraordinaries
85
94
78
54
2
Net Income Available to Common
84
169
78
54
2
EPS (Basic)
0.69
2.13
0.67
0.47
0.02
Basic Shares Outstanding
121
115
116
116
117
EPS (Diluted)
0.68
2.13
0.67
0.47
0.02
Diluted Shares Outstanding
121
115
116
116
117
Other Operating Expense
-
-
390
366
340
Minority Interest Expense
-
-
-
-
-
Equity in Affiliates (Pretax)
-
-
-
-
-
Other After Tax Income (Expense)
-
-
-
-
-
Preferred Dividends
-
-
-
-
-
About Coherus BioSciences
View Profile
